Reversible inhibition of lysine specific demethylase 1 is a novel anti-tumor strategy for poorly differentiated endometrial carcinomaEmily R. Theisen, Margit M. Janát‐Amsbury|BMC Cancer|2014Cited by 50
Transcriptomic analysis functionally maps the intrinsically disordered domain of EWS/FLI and reveals novel transcriptional dependencies for oncogenesisEmily R. Theisen, Stephen L. Lessnick|Genes & Cancer|2019Cited by 30
Seclidemstat blocks the transcriptional function of multiple FET-fusion oncoproteinsGalen Rask, Emily R. Theisen, Cenny Taslim et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 3
<i>N</i> ′-(1-Phenylethylidene)benzohydrazide Cytotoxicity Is Lysine-Specific Demethylase 1 Independent and Linked to Iron–Sulfur Cluster Disruption in Ewing SarcomaJohn Sherman, Emily R. Theisen, Galen Rask et al.|ACS Pharmacology & Translational Science|2025Cited by 2
Abstract P087: Targeting LSD1 protein scaffolding function in FET-rearranged sarcomas with SP-2577Galen Rask, Daniela Y. Santiesteban, Emily R. Theisen et al.|Molecular Cancer Therapeutics|2021Cited by 1